A recent study published in the Journal of Affective Disorders suggests that a single dose of psilocybin may offer hope for U ...

FOR decades, Sarah Smith suffered with depression. But now, due to a futuristic-looking headset that zapped electronic pulses deep into her brain, her fog has lifted. She tells Sun Health: “It’s ...

Analyst Vikram Purohit of Morgan Stanley maintained a Buy rating on COMPASS Pathways (CMPS – Research Report), with a price target of ...

Psychedelic mushrooms, containing the active ingredient psilocybin, have shown remarkable potential in treating various mental health conditions, including treatment-resistant depression. Leading ...

State lawmakers are considering a bill that would legalize production and use of psilocybin as a mental health treatment in ...

Compass Pathways is advancing pivotal trials to test psilocybin's impact on treatment-resistant depression. See why I rate ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Esketamine nasal spray (Spravato) monotherapy ...

Collaboration with Sunnybrook, brings rTMS brain stimulattion technology ‘closer to home'. 'We all know the need for ...

A groundbreaking study reveals that a portable electrostimulation device could revolutionize the treatment of severe ...

Esketamine for TRD demonstrated efficacy in reducing depressive symptoms and did not significantly differ based on TMS treatment history.